Aura Biosciences Inc. (AURA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aura Biosciences Inc.

    NASDAQ: AURA · Real-Time Price · USD
    6.48
    0.06 (0.93%)
    At close: Sep 05, 2025, 3:59 PM
    6.48
    0.00%
    After-hours: Sep 05, 2025, 05:34 PM EDT

    Aura Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 1.22M 1.29M 1.18M 835K
    Gross Profit
    		 -1.22M -1.29M -1.18M -835K
    Operating Income
    		 -96.12M -84.99M -60.3M -35.25M
    Interest Income
    		 9.43M 8.59M 1.86M 13K
    Pretax Income
    		 -86.81M -76.27M -58.76M -35.25M
    Net Income
    		 -86.92M -76.41M -58.76M -35.25M
    Selling & General & Admin
    		 22.81M 19.76M 18.06M 10.09M
    Research & Development
    		 73.3M 63.94M 42.24M 25.16M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 96.12M 83.7M 60.3M 35.25M
    Interest Expense
    		 n/a n/a n/a 13K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -96.12M 84.99M 60.3M 35.25M
    Income Tax Expense
    		 112K 137K -1.53M -830K
    Shares Outstanding (Basic)
    		 49.65M 39.62M 29.94M 29.21M
    Shares Outstanding (Diluted)
    		 49.65M 39.62M 29.94M 29.21M
    EPS (Basic)
    		 -1.75 -1.93 -1.96 -1.58
    EPS (Diluted)
    		 -1.75 -1.93 -1.96 -1.58
    EBITDA
    		 -85.58M -83.7M -59.12M -34.42M
    EBIT
    		 -86.81M -84.99M -60.3M -35.25M
    Depreciation & Amortization
    		 1.22M 1.29M 1.18M 835K

    Add to Watchlist